41 – 60 of 102
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients
(
- Contribution to journal › Article
-
Mark
Hälsoekonomiska modeller vid diabetes: ett hjälpmedel för klinisk forskning och behandlingsval
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Societal Value of Stem Cell Therapy in Stroke - A Modeling Study.
(
- Contribution to journal › Article
- 2011
-
Mark
Missbrukets ekonomiska börda i Sverige
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Värdet av nya läkemedel: en förstudie
2011)(
- Contribution to conference › Paper, not in proceeding
-
Mark
Practical issues in handling data input and uncertainty in a budget impact analysis
(
- Contribution to journal › Article
-
Mark
Acquisition cost of dispensed drugs in individuals with multiple medications A register-based study in Sweden
(
- Contribution to journal › Article
-
Mark
Effect of Treatment with Natalizumab on Ability to Work in People with Multiple Sclerosis Productivity Gain Based on Direct Measurement of Work Capacity before and after 1 Year of Treatment
(
- Contribution to journal › Article
- 2010
-
Mark
The Value of Informal Caregiver Time for Psychotic Illness
(
- Contribution to journal › Article
-
Mark
Willingness to pay for health improvements of physical activity on prescription.
(
- Contribution to journal › Article
-
Mark
Vilken betysdelse har hälsoekonomi vid prioriteringar? Ett experiment bland beslutsfattare och en analys av faktiska prioriteringar.
2010)(
- Book/Report › Report
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
- 2009
-
Mark
Costs associated with sharps injuries in the Swedish health care setting and potential cost savings from needle-stick prevention devices with needle and syringe.
(
- Contribution to journal › Article
-
Mark
Viktigt hålla fast vid principen om värdebaserad prissättning av läkemedel.
(
- Contribution to journal › Article
-
Mark
Physical activity on prescription (PAP): Costs and consequences of a randomized, controlled trial in primary healthcare.
(
- Contribution to journal › Article
- 2008
-
Mark
The Swedish cost burden of overweight and obesity - Evaluated with the PAR approach and a statistical modelling approach
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
(
- Contribution to journal › Article
-
Mark
Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
(
- Contribution to journal › Article
- 2007
-
Mark
Cost-effectiveness analysis of treatment with epoietin-alpha for patients with anaemia due to renal failure: The case of Sweden.
(
- Contribution to journal › Article
-
Mark
Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden
(
- Contribution to journal › Article